[SCHEDULE 13G/A] 89bio, Inc. SEC Filing
Janus Henderson Group plc reports beneficial ownership of 5,378,185 shares of 89bio, Inc. common stock, representing
Janus Henderson Group plc riferisce la proprietà beneficiaria di 5.378.185 azioni di 89bio, Inc. azioni ordinarie, che rappresentano
Janus Henderson Group plc reporta la titularidad beneficiaria de 5.378.185 acciones de 89bio, Inc. acciones ordinarias, representando
Janus Henderson Group plc는 89bio, Inc.의 보통주 5,378,185주에 대한 유익한 소유를 보고하며, 이는 클래스의
Janus Henderson Group plc déclare la propriété bénéficiaire de 5 378 185 actions ordinaires de 89bio, Inc., représentant
Janus Henderson Group plc meldet wirtschaftliches Eigentum an 5.378.185 Aktien von 89bio, Inc. Stammaktien, die
Janus Henderson Group plc يعلن الملكية المفيدة لـ 5,378,185 سهماً من أسهم 89bio, Inc. العادية، تشكل
Janus Henderson Group plc 报告对 89bio, Inc. 普通股拥有受益所有权,共计 5,378,185 股,约占该类别的
- Transparent disclosure of aggregate ownership at
3.6% (5,378,185 shares) - Subsidiary ownership detail provided: JHIUS beneficial owner of 5,052,254 shares (
3.4% ) - Certification states holdings are in the ordinary course of business, not for control purposes
- No holdings exceed 5%, so this position is unlikely to trigger enhanced shareholder influence
- Shared voting/dispositive power only, limiting clarity on direct control over votes or dispositions
Insights
Large institutional stake below 5% signals passive investment exposure.
Janus Henderson Group plc holds
The holding is material enough to warrant monitoring but does not meet the >5% threshold that typically triggers greater regulatory or market scrutiny. Watch subsequent amendment filings for changes in stake size or shifts from shared to sole voting/dispositive power over the next reporting periods.
Filing follows Schedule 13G format and affirms ordinary-course investment intent.
The statement classifies the filer under investment adviser and holding company types and includes a certification that the securities are held in the ordinary course of business and not to change control. It also attaches a power of attorney that authorizes compliance officers to make future ownership filings.
Investors should note the certification language and the existence of delegated filing authority; any future amendments that change the stated intent or the nature of voting/dispositive power would be the concrete signals to monitor in subsequent filings.
Janus Henderson Group plc riferisce la proprietà beneficiaria di 5.378.185 azioni di 89bio, Inc. azioni ordinarie, che rappresentano
Janus Henderson Group plc reporta la titularidad beneficiaria de 5.378.185 acciones de 89bio, Inc. acciones ordinarias, representando
Janus Henderson Group plc는 89bio, Inc.의 보통주 5,378,185주에 대한 유익한 소유를 보고하며, 이는 클래스의
Janus Henderson Group plc déclare la propriété bénéficiaire de 5 378 185 actions ordinaires de 89bio, Inc., représentant
Janus Henderson Group plc meldet wirtschaftliches Eigentum an 5.378.185 Aktien von 89bio, Inc. Stammaktien, die